About Excedr
Excedr is a Healthcare company. Scientific equipment leasing services for biotech and life sciences companies. It operates in the Healthcare and Agriculture sectors. Excedr has raised $8 million across 2 funding rounds from investors including BOK Financial. Excedr offers products and services including Equipment Leasing and Analytical Instruments. Its focus areas include Biotechnology, Life Sciences, Equipment Leasing and Scientific Instruments.
Company details
Excedr has been utilized as a leasing provider for scientific equipment since 2011, focusing on biotech and life sciences sectors. Flexible lease terms are offered to extend cash runways and support RD milestones without equity dilution. Testimonials from company leaders indicate that equipment procurement and maintenance are handled efficiently, allowing research to progress. Various instruments, including chromatography and microscopes, are sourced and tailored to workflows, while maintenance hassles are minimized to aid scaling efforts.
- Total Equity Funding$8M (USD)
in 2 rounds
- Latest Funding Round$8M (USD), Series A
Jul 2026
- Investors
Products & Services of Excedr
Excedr offers a comprehensive portfolio of products and services, including Equipment Leasing and Analytical Instruments.
Leasing of scientific equipment is provided to support biotech and life sciences operations
Instruments such as chromatography and spectroscopy equipment are made available through leasing arrangements
Apps and channels of Excedr
its YouTube channel The Biotech Startups Podcast | Excedr has 1.93K subscribers and 30 videos.
Videos from Excedr
The most watched videos on Excedr's YouTube channel, The Biotech Startups Podcast | Excedr (1.93K subscribers). Click a video to play it here.
Funding Insights of Excedr
Excedr has successfully raised a total of $8M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8M
- Total Rounds 2
- Last Round Series A — $8M
- First Round $17M
(Jul 2026)
- Investors Count 1
All 2 funding rounds of Excedr with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | $17M | Debt – Conventional | – | – | |
| Jul 2026 | $8M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Excedr
Excedr has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BOK Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| bokfinancial.com |
Investor details for Excedr
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Excedr
7 people are tracked at Excedr (3 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Sylvia Marton | Director, Strategic Partnerships & Operations | Leadership |
Jon Chee | CEO & Co-founder | Leadership |
Robert Clemens | Director Of Strategic Finance | Leadership |
Patrycja Bugajska | Account Manager | Team |
Chloe Medosch | Customer Success Advisor | Team |
Nick McAfee | Marketing Manager | Team |
Tara Fowler | Sales Representative | Team |
Complete people profiles for Excedr
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Excedr
Websites that share an audience with Excedr (excedr.com).
Websites whose visitors overlap most with Excedr. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| blockimaging.com | 70% | 67.1K | #579,281 | View details | |
| labiotech.eu | 70% | 200.5K | #249,174 | View details | |
| novotech-cro.com | 59% | 49.2K | #897,361 | View details | |
| alderleypark.co.uk | 58% | 3.2K | #5,166,095 | View details | |
| sunpharma.com | 49% | 216K | #177,160 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Excedr
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Excedr
Excedr is a funded company, having raised a total of $8M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $17M, raised on Jul 2026.
Excedr has been utilized as a leasing provider for scientific equipment since 2011, focusing on biotech and life sciences sectors. Flexible lease terms are offered to extend cash runways and support RD milestones without equity dilution. Testimonials from company leaders indicate that equipment procurement and maintenance are handled efficiently, allowing research to progress. Various instruments, including chromatography and microscopes, are sourced and tailored to workflows, while maintenance hassles are minimized to aid scaling efforts.
Excedr offers Equipment Leasing and Analytical Instruments.
Excedr has 1 investor. Key investors include BOK Financial.
Excedr operates through Excedr.